Lamivudine (Epivir)
Revision as of 01:01, 29 June 2024 by Warner-admin (talk | contribs) (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
General information
Class/mechanism: Antiretroviral; Lamivudine is a cytidine analog and can inhibit both types (1 and 2) of HIV reverse transcriptase and also the reverse transcriptase of hepatitis B.
Route: PO
Extravasation: N/A
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used for prevention of HBV reactivation for HBV carriers.
Also known as
- Brand name: Epivir